MiMedx corrects termination fees in Sanara merger; Sanara fee $9.66M, MiMedx fee $22.54M

MIMEDX GROUP, INC.

Termination fee payable by Sanara to MiMedx corrected to $9,660,336 (previously misstated as $22,540,785).
Termination fee payable by MiMedx to Sanara corrected to $22,540,785 (previously misstated as $9,660,336).
Merger consideration: $33.00 cash + 0.4735 MiMedx shares per Sanara share (stock portion valued at ~$2.00).
MiMedx secured $300M first-lien senior secured term loan from Hayfin Capital Management for the merger.
Voting agreement with Sanara stockholders holding ~38.9% of voting power to support the deal.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.